(+)-schisandrin B multiple interactions ISO RGD:1310749 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NFATC4 mRNA] CTD PMID:31150632 (S)-colchicine decreases localization ISO RGD:1321836 6480464 Colchicine results in decreased localization of NFATC4 protein CTD PMID:17044076 17beta-estradiol affects expression ISO RGD:1321836 6480464 Estradiol affects the expression of NFATC4 mRNA CTD PMID:22574217 17beta-estradiol multiple interactions ISO RGD:1321836 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of NFATC4 mRNA, IGF1R mutant form inhibits the reaction [Estradiol results in decreased expression of NFATC4 mRNA] CTD PMID:23094148 , PMID:30165855 17beta-estradiol decreases expression ISO RGD:1321836 6480464 Estradiol results in decreased expression of NFATC4 mRNA CTD PMID:23094148 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of NFATC4 mRNA CTD PMID:21570461 , PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1310749 6480464 Tetrachlorodibenzodioxin results in increased expression of NFATC4 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of NFATC4 mRNA CTD PMID:18691609 , PMID:19933214 20-HETE multiple interactions ISO RGD:1321836 6480464 Cyclosporine inhibits the reaction [20-hydroxy-5 more ... CTD PMID:16055480 20-HETE increases localization ISO RGD:1310749 6480464 20-hydroxy-5 more ... CTD PMID:16055480 20-HETE multiple interactions ISO RGD:1310749 6480464 Cyclosporine inhibits the reaction [20-hydroxy-5 more ... CTD PMID:16055480 20-HETE increases localization ISO RGD:1321836 6480464 20-hydroxy-5 more ... CTD PMID:16055480 3,3',5,5'-tetrabromobisphenol A decreases expression EXP 6480464 tetrabromobisphenol A results in decreased expression of NFATC4 mRNA CTD PMID:25172293 6-propyl-2-thiouracil increases expression ISO RGD:1310749 6480464 Propylthiouracil results in increased expression of NFATC4 mRNA CTD PMID:24780913 acetamide increases expression ISO RGD:1310749 6480464 acetamide results in increased expression of NFATC4 mRNA CTD PMID:31881176 all-trans-retinoic acid decreases expression ISO RGD:1310749 6480464 Tretinoin results in decreased expression of NFATC4 mRNA CTD PMID:20488242 antirheumatic drug increases expression ISO RGD:1321836 6480464 Antirheumatic Agents results in increased expression of NFATC4 mRNA CTD PMID:24449571 benzo[a]pyrene decreases expression ISO RGD:1321836 6480464 Benzoapyrene results in decreased expression of NFATC4 mRNA CTD PMID:32234424 bisphenol A decreases expression ISO RGD:1310749 6480464 bisphenol A results in decreased expression of NFATC4 mRNA CTD PMID:25181051 bisphenol A affects methylation EXP 6480464 bisphenol A affects the methylation of NFATC4 promoter CTD PMID:27334623 cadmium dichloride increases expression ISO RGD:1321836 6480464 Cadmium Chloride results in increased expression of NFATC4 mRNA CTD PMID:32512071 Calcimycin multiple interactions ISO RGD:1321836 6480464 NFATC4 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein] CTD PMID:21603612 capsaicin increases localization ISO RGD:1310749 6480464 Capsaicin results in increased localization of NFATC4 protein CTD PMID:16849427 carboplatin multiple interactions EXP 6480464 HMOX1 protein inhibits the reaction [Carboplatin results in increased activity of NFATC4] CTD PMID:21198546 carboplatin multiple interactions ISO RGD:1310749 6480464 HMOX1 protein inhibits the reaction [Carboplatin results in increased activity of NFATC4] CTD PMID:21198546 carboplatin increases activity ISO RGD:1310749 6480464 Carboplatin results in increased activity of NFATC4 CTD PMID:21198546 carboplatin increases activity EXP 6480464 Carboplatin results in increased activity of NFATC4 CTD PMID:21198546 carvedilol increases phosphorylation ISO RGD:1310749 6480464 carvedilol results in increased phosphorylation of NFATC4 protein CTD PMID:21472269 chlorohydrocarbon multiple interactions ISO RGD:1310749 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of NFATC4 mRNA CTD PMID:30744511 cisplatin multiple interactions ISO RGD:1321836 6480464 [Cisplatin co-treated with Quercetin] results in increased expression of NFATC4 mRNA CTD PMID:27514524 cisplatin decreases phosphorylation EXP 6480464 Cisplatin results in decreased phosphorylation of NFATC4 protein CTD PMID:22006019 cyclosporin A multiple interactions ISO RGD:1321836 6480464 Cyclosporine inhibits the reaction [20-hydroxy-5 more ... CTD PMID:16055480 cyclosporin A multiple interactions ISO RGD:1310749 6480464 Cyclosporine inhibits the reaction [20-hydroxy-5 more ... CTD PMID:16055480 , PMID:21606195 cytochalasin D decreases localization ISO RGD:1321836 6480464 Cytochalasin D results in decreased localization of NFATC4 protein CTD PMID:17044076 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of NFATC4 mRNA CTD PMID:21266533 dorsomorphin multiple interactions ISO RGD:1321836 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 endosulfan affects expression ISO RGD:1310749 6480464 Endosulfan affects the expression of NFATC4 mRNA CTD PMID:31464424 entinostat decreases expression ISO RGD:1321836 6480464 entinostat results in decreased expression of NFATC4 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1321836 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of NFATC4 mRNA CTD PMID:27188386 ethanol decreases expression ISO RGD:1310749 6480464 Ethanol results in decreased expression of NFATC4 mRNA CTD PMID:20655511 fenofibrate multiple interactions ISO RGD:1310749 6480464 EDN1 protein promotes the reaction [Fenofibrate promotes the reaction [NFATC4 protein binds to PPARA protein]] more ... CTD PMID:22198280 fructose increases expression ISO RGD:1310749 6480464 Fructose results in increased expression of NFATC4 protein CTD PMID:26358169 fructose multiple interactions ISO RGD:1310749 6480464 tributylhexadecylphosphonium bromide inhibits the reaction [Fructose results in increased expression of NFATC4 protein] CTD PMID:26358169 harmine affects localization ISO RGD:1321836 6480464 Harmine affects the localization of NFATC4 protein CTD PMID:25751815 ionomycin increases localization ISO RGD:1310749 6480464 Ionomycin results in increased localization of NFATC4 protein CTD PMID:16849427 ionomycin multiple interactions ISO RGD:1310749 6480464 Cyclosporine inhibits the reaction [Ionomycin promotes the reaction [NFATC4 protein results in increased expression of RCAN1 mRNA]] more ... CTD PMID:21606195 lead(0) decreases phosphorylation ISO RGD:1321836 6480464 Lead results in decreased phosphorylation of NFATC4 protein CTD PMID:25193092 lead(2+) decreases phosphorylation ISO RGD:1321836 6480464 Lead results in decreased phosphorylation of NFATC4 protein CTD PMID:25193092 mercury atom increases expression ISO RGD:1321836 6480464 Mercury results in increased expression of NFATC4 mRNA CTD PMID:19937285 mercury(0) increases expression ISO RGD:1321836 6480464 Mercury results in increased expression of NFATC4 mRNA CTD PMID:19937285 methamphetamine affects localization ISO RGD:1310749 6480464 Methamphetamine affects the localization of NFATC4 protein CTD PMID:15644446 methamphetamine decreases expression ISO RGD:1310749 6480464 Methamphetamine results in decreased expression of NFATC4 mRNA CTD PMID:19564919 methamphetamine multiple interactions ISO RGD:1310749 6480464 [Methamphetamine co-treated with SCH 23390] results in decreased expression of NFATC4 mRNA, SCH 23390 inhibits the reaction [Methamphetamine affects the localization of NFATC4 protein] CTD PMID:15644446 , PMID:19564919 methylmercury chloride multiple interactions ISO RGD:1310749 6480464 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in increased expression of NFATC4 mRNA CTD PMID:30744511 metoprolol increases phosphorylation ISO RGD:1310749 6480464 Metoprolol results in increased phosphorylation of NFATC4 protein CTD PMID:21472269 N-methyl-4-phenylpyridinium decreases expression ISO RGD:1321836 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of NFATC4 mRNA CTD PMID:25234470 nickel atom multiple interactions ISO RGD:1321836 6480464 NFATC4 mRNA affects the reaction [Nickel results in increased expression of PTGS2] CTD PMID:21486220 nickel atom decreases expression ISO RGD:1321836 6480464 Nickel results in decreased expression of NFATC4 mRNA CTD PMID:24768652 , PMID:25583101 nickel subsulfide decreases expression ISO RGD:1310749 6480464 nickel subsulfide results in decreased expression of NFATC4 mRNA CTD PMID:24952340 panobinostat decreases expression ISO RGD:1321836 6480464 panobinostat results in decreased expression of NFATC4 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:1321836 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of NFATC4 mRNA CTD PMID:27188386 phenylephrine multiple interactions ISO RGD:1321836 6480464 Cyclosporine inhibits the reaction [Phenylephrine results in increased localization of NFATC4 protein], Tacrolimus inhibits the reaction [Phenylephrine results in increased localization of NFATC4 protein] CTD PMID:16055480 phenylephrine increases localization ISO RGD:1310749 6480464 Phenylephrine results in increased localization of NFATC4 protein CTD PMID:16055480 phenylephrine affects localization ISO RGD:1310749 6480464 Phenylephrine affects the localization of NFATC4 protein CTD PMID:11044444 phenylephrine multiple interactions ISO RGD:1310749 6480464 2-2-amino-3-methoxyphenyl-4H-1-benzopyran-4-one inhibits the reaction [Phenylephrine affects the localization of NFATC4 protein] more ... CTD PMID:11044444 , PMID:16055480 phenylephrine increases localization ISO RGD:1321836 6480464 Phenylephrine results in increased localization of NFATC4 protein CTD PMID:16055480 phenylmercury acetate decreases expression ISO RGD:1321836 6480464 Phenylmercuric Acetate results in decreased expression of NFATC4 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1321836 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of NFATC4 mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1321836 6480464 NFATC4 protein promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNFSF10 protein] CTD PMID:21603612 quercetin multiple interactions ISO RGD:1321836 6480464 [Cisplatin co-treated with Quercetin] results in increased expression of NFATC4 mRNA CTD PMID:27514524 SB 431542 multiple interactions ISO RGD:1321836 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 SCH 23390 multiple interactions ISO RGD:1310749 6480464 [Methamphetamine co-treated with SCH 23390] results in decreased expression of NFATC4 mRNA, SCH 23390 inhibits the reaction [Methamphetamine affects the localization of NFATC4 protein] CTD PMID:15644446 , PMID:19564919 silver atom decreases expression EXP 6480464 Silver results in decreased expression of NFATC4 mRNA CTD PMID:27131904 silver(0) decreases expression EXP 6480464 Silver results in decreased expression of NFATC4 mRNA CTD PMID:27131904 sodium arsenite multiple interactions ISO RGD:1321836 6480464 NFATC4 protein promotes the reaction [sodium arsenite results in increased expression of PTGS2 protein] CTD PMID:16809336 sodium arsenite affects expression ISO RGD:1321836 6480464 sodium arsenite affects the expression of NFATC4 mRNA CTD PMID:29319823 sodium arsenite increases activity ISO RGD:1321836 6480464 sodium arsenite results in increased activity of NFATC4 protein CTD PMID:16809336 tacrolimus hydrate multiple interactions ISO RGD:1321836 6480464 Tacrolimus inhibits the reaction [20-hydroxy-5 more ... CTD PMID:16055480 tacrolimus hydrate multiple interactions ISO RGD:1310749 6480464 Tacrolimus inhibits the reaction [20-hydroxy-5 more ... CTD PMID:16055480 tetrachloromethane decreases expression ISO RGD:1310749 6480464 Carbon Tetrachloride results in decreased expression of NFATC4 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions ISO RGD:1310749 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NFATC4 mRNA] CTD PMID:31150632 thioacetamide increases expression ISO RGD:1310749 6480464 Thioacetamide results in increased expression of NFATC4 mRNA CTD PMID:23411599 toluene increases expression ISO RGD:1310749 6480464 Toluene results in increased expression of NFATC4 mRNA CTD PMID:22967744 trichostatin A decreases expression ISO RGD:1321836 6480464 trichostatin A results in decreased expression of NFATC4 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1321836 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of NFATC4 mRNA CTD PMID:27188386 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of NFATC4 mRNA CTD PMID:21427059 valproic acid increases expression ISO RGD:1321836 6480464 Valproic Acid results in increased expression of NFATC4 mRNA CTD PMID:29501571 valproic acid multiple interactions ISO RGD:1321836 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of NFATC4 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1321836 6480464 Valproic Acid results in decreased expression of NFATC4 mRNA CTD PMID:23179753 more ... valproic acid increases methylation ISO RGD:1321836 6480464 Valproic Acid results in increased methylation of NFATC4 gene CTD PMID:29154799 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of NFATC4 mRNA CTD PMID:21427059 vincaleukoblastine decreases localization ISO RGD:1321836 6480464 Vinblastine results in decreased localization of NFATC4 protein CTD PMID:17044076 vorinostat decreases expression ISO RGD:1321836 6480464 vorinostat results in decreased expression of NFATC4 mRNA CTD PMID:27188386 WIN 55212-2 increases localization ISO RGD:1310749 6480464 Win 55212-2 results in increased localization of NFATC4 protein CTD PMID:16849427 zinc atom increases localization ISO RGD:1321836 6480464 Zinc results in increased localization of NFATC4 protein CTD PMID:17044076 zinc(0) increases localization ISO RGD:1321836 6480464 Zinc results in increased localization of NFATC4 protein CTD PMID:17044076